WALRF yields 2436.05% · JNJ yields 2.14%● Live data
📍 WALRF pulled ahead of the other in Year 1
Combined, WALRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WALRF + JNJ for your $10,000?
MegaWatt Lithium and Battery Metals Corp. engages in the acquisition, exploration, and development of mineral properties in Canada and Australia. It holds a 100% interest in the Route 381 Lithium property that consists of 40 mineral claims covering an area of approximately 2,126 hectares located in James Bay Territory in the Province of Quebec. The company also holds interest in the Tyr silver project and Century South silver-zinc project located in Australia. In addition, it holds an option to acquire a 100% interest in the Cobalt Hill property that consists of eight mineral claims covering an area of approximately 1,727.43 hectares located in the Trail Creek Mining division in British Columbia. The company was formerly known as Walcott Resources Ltd. and changed its name to MegaWatt Lithium and Battery Metals Corp. in February 2021. MegaWatt Lithium and Battery Metals Corp. was incorporated in 2017 and is based in Vancouver, Canada.
Full WALRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.